Skip to main content

. 1964 Aug;27(4):345–350. doi: 10.1136/jnnp.27.4.345

Myasthenia gravis with hypergammaglobulinaemia and antibodies

H J G H Oosterhuis ^1,², H Van Der Geld ^1,², T E W Feltkamp ^1,², F Peetoom ^1,²

PMCID: PMC495756 PMID: 14200790

345

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BEUTNER E. H., WITEBSKY E., RICKEN D., ADLER R. H. Studies on autoantibodies in myasthenia gravis. JAMA. 1962 Oct 6;182:46–58. [PubMed] [Google Scholar]
CASTAIGNE P., LHERMITTE F., ESCOUROLLE R., MARTIN, BINET J. L. [Myasthenia, thymic tumor and aplastic anemia]. Rev Neurol (Paris) 1961 Nov;105:373–389. [PubMed] [Google Scholar]
DE HAENE A., ROUSSEL J. Syndrome myasthéniforme ou myasthénie vraie avec dissociation albumino-cytologique dans le liquide céphalo-rachidien et étude musculaire. Acta Neurol Psychiatr Belg. 1955 Apr;55(4):364–368. [PubMed] [Google Scholar]
DESMEDT J. E. Myasthenic-like features of neuromuscular transmission after administration of an inhibitor of acetylcholine synthesis. Nature. 1958 Dec 13;182(4650):1673–1674. doi: 10.1038/1821673a0. [DOI] [PubMed] [Google Scholar]
FELTKAMP T. E., van der GELD, KRUYFF K., OOSTERHUIS H. J. Antinuclear factor in myasthenia gravis. Lancet. 1963 Mar 23;1(7282):667–667. doi: 10.1016/s0140-6736(63)91302-3. [DOI] [PubMed] [Google Scholar]
FELTKAMP T. E., van der GELD, OOSTERHUIS H. J. Studies on sera from cases of myasthenia gravis, using the fluorescent antibody technique. Vox Sang. 1963 May-Jun;8:317–327. [PubMed] [Google Scholar]
LAMBIE A. T., BURROWS B. A., SOMMERS S. C. Clinicopathologic conference; refractory anemia, agammaglobulinemia, and mediastinal tumor. Am J Clin Pathol. 1957 Apr;27(4):444–452. doi: 10.1093/ajcp/27.4.444. [DOI] [PubMed] [Google Scholar]
LOWENTHAL A., VAN SANDE M. Nouvelles déterminations des fractions protéiniques dans le sérum de patients atteints d'affections musculaires. Rev Fr Etud Clin Biol. 1956 Sep;1(7):765–771. [PubMed] [Google Scholar]
NASTUK W. L., PLESCIA O. J., OSSERMAN K. E. Changes in serum complement activity in patients with myasthenia gravis. Proc Soc Exp Biol Med. 1960 Oct;105:177–184. doi: 10.3181/00379727-105-26050. [DOI] [PubMed] [Google Scholar]
NASTUK W. L., PLESCIA O. J., OSSERMAN K. E. Changes in serum complement activity in patients with myasthenia gravis. Proc Soc Exp Biol Med. 1960 Oct;105:177–184. doi: 10.3181/00379727-105-26050. [DOI] [PubMed] [Google Scholar]
VAN DER GELD H., FELTKAMP T. E., OOSTERHUIS H. J. REACTIVITY OF MYASTHENIA GRAVIS SERUM GAMMA-GLOBULIN WITH SKELETAL MUSCLE AND THYMUS DEMONSTRATED BY IMMUNOFLUORESCENCE. Proc Soc Exp Biol Med. 1964 Mar;115:782–785. doi: 10.3181/00379727-115-29037. [DOI] [PubMed] [Google Scholar]
VAN DER GELD H., FELTKAMP T. E., VAN LOGHEM J., OOSTERHUIS H. J., BIEMOND A. MULTIPLE ANTIBODY PRODUCTION IN MYASTHENIA GRAVIS. Lancet. 1963 Aug 24;2(7304):373–375. doi: 10.1016/s0140-6736(63)93055-1. [DOI] [PubMed] [Google Scholar]
WHITE R. G., MARSHALL A. H. The autoimmune response in myasthenia gravis. Lancet. 1962 Jul 21;2(7247):120–123. doi: 10.1016/s0140-6736(62)90005-3. [DOI] [PubMed] [Google Scholar]
ZACKS S. I., BAUER W. C., BLUMBERG J. M. The fine structure of the myasthenic neuromuscular junction. J Neuropathol Exp Neurol. 1962 Jul;21:335–347. doi: 10.1097/00005072-196207000-00001. [DOI] [PubMed] [Google Scholar]
van der GELD, OOSTERHUIS H. J. Muscle and thymus antibodies in myasthenia gravis. Vox Sang. 1963 Mar-Apr;8:196–204. doi: 10.1111/j.1423-0410.1963.tb03293.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES